16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The maxillofacial skeleton is highly dynamic and requires a constant equilibrium between the bone resorption and bone formation. The field of osteoimmunology explores the interactions between bone metabolism and the immune response, providing a context to study the complex cellular and molecular networks involved in oro-maxillofacial osteolytic diseases. In this review, we present a framework for understanding the potential mechanisms underlying the immuno-pathobiology in etiologically-diverse diseases that affect the oral and maxillofacial region and share bone destruction as their common clinical outcome. These otherwise different pathologies share similar inflammatory pathways mediated by central cellular players, such as macrophages, T and B cells, that promote the differentiation and activation of osteoclasts, ineffective or insufficient bone apposition by osteoblasts, and the continuous production of osteoclastogenic signals by immune and local stromal cells. We also present the potential translational applications of this knowledge based on the biological mechanisms involved in the inflammation-induced bone destruction. Such applications can be the development of immune-based therapies that promote bone healing/regeneration, the identification of host-derived inflammatory/collagenolytic biomarkers as diagnostics tools, the assessment of links between oral and systemic diseases; and the characterization of genetic polymorphisms in immune or bone-related genes that will help diagnosis of susceptible individuals.

          Related collections

          Most cited references217

          • Record: found
          • Abstract: found
          • Article: not found

          T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

          T cell functional differentiation is mediated by lineage-specific transcription factors. T helper 17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation. Retinoic acid receptor-related orphan receptor gamma (ROR gamma) was shown to regulate Th17 differentiation; ROR gamma deficiency, however, did not completely abolish Th17 cytokine expression. Here, we report Th17 cells highly expressed another related nuclear receptor, ROR alpha, induced by transforming growth factor-beta and interleukin-6 (IL-6), which is dependent on signal transducer and activator of transcription 3. Overexpression of ROR alpha promoted Th17 differentiation, possibly through the conserved noncoding sequence 2 in Il17-Il17f locus. ROR alpha deficiency resulted in reduced IL-17 expression in vitro and in vivo. Furthermore, ROR alpha and ROR gamma coexpression synergistically led to greater Th17 differentiation. Double deficiencies in ROR alpha and ROR gamma globally impaired Th17 generation and completely protected mice against experimental autoimmune encephalomyelitis. Therefore, Th17 differentiation is directed by two lineage-specific nuclear receptors, ROR alpha and ROR gamma.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The epidemiology of osteoarthritis.

            Osteoarthritis (OA) is a leading cause of disability and its incidence is rising due to increasing obesity and an ageing population. Risk factors can be divided into person-level factors, such as age, sex, obesity, genetics, race/ethnicity and diet, and joint-level factors including injury, malalignment and abnormal loading of the joints. The interaction of these risk factors is complex and provides a challenge to the managing physician. The purpose of this review is to illustrate how each of these factors interact together to instigate incident OA as well as to outline the need for ongoing epidemiologic studies for the future prevention of both incident and progressive OA. It is only by understanding the impact of this disease and the modifiable risk factors that we will be able to truly target public health prevention interventions appropriately.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Proresolving lipid mediators and mechanisms in the resolution of acute inflammation.

              Inflammatory responses, like all biological cascades, are shaped by a delicate balance between positive and negative feedback loops. It is now clear that in addition to positive and negative checkpoints, the inflammatory cascade rather unexpectedly boasts an additional checkpoint, a family of chemicals that actively promote resolution and tissue repair without compromising host defense. Indeed, the resolution phase of inflammation is just as actively orchestrated and carefully choreographed as its induction and inhibition. In this review, we explore the immunological consequences of omega-3-derived specialized proresolving mediators (SPMs) and discuss their place within what is currently understood of the role of the arachidonic acid-derived prostaglandins, lipoxins, and their natural C15-epimers. We propose that treatment of inflammation should not be restricted to the use of inhibitors of the acute cascade (antagonism) but broadened to take account of the enormous therapeutic potential of inducers (agonists) of the resolution phase of inflammation.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Immunol
                Front Immunol
                Front. Immunol.
                Frontiers in Immunology
                Frontiers Media S.A.
                1664-3224
                18 July 2019
                2019
                : 10
                : 1664
                Affiliations
                [1] 1Forsyth Institute , Cambridge, MA, United States
                [2] 2Periodontal Biology Laboratory, Faculty of Dentistry, Universidad de Chile , Santiago, Chile
                [3] 3Department of Conservative Dentistry, Faculty of Dentistry, Universidad de Chile , Santiago, Chile
                [4] 4Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, San Jose's Hospital and Clínica Las Condes, Universidad de Chile , Santiago, Chile
                [5] 5INSERM, UMR 1232, LabCT, CRCINA, Institut de Cancérologie de l'Ouest, Université de Nantes, Université d'Angers , Saint-Herblain, France
                [6] 6Department of Biological Sciences, Bauru School of Dentistry, University of São Paulo , Bauru, Brazil
                [7] 7Department of Oral and Maxillofacial Diseases, University of Helsinki, Helsinki University Hospital , Helsinki, Finland
                [8] 8Department of Oral Diseases, Karolinska Institutet , Stockholm, Sweden
                [9] 9Department of Oral Biology and Pathology, School of Dental Medicine, Stony Brook University , Stony Brook, NY, United States
                [10] 10Dentistry Unit, Faculty of Health Sciences, Universidad Autónoma de Chile , Santiago, Chile
                Author notes

                Edited by: Teun J. De Vries, VU University Amsterdam, Netherlands

                Reviewed by: Dana T. Graves, University of Pennsylvania, United States; Jérôme Bouchet, Université Paris Descartes, France

                *Correspondence: Alpdogan Kantarci akantarci@ 123456forsyth.org

                This article was submitted to Inflammation, a section of the journal Frontiers in Immunology

                Article
                10.3389/fimmu.2019.01664
                6657671
                31379856
                7ce276a9-93ce-4518-83b7-ec70c1fe7665
                Copyright © 2019 Alvarez, Monasterio, Cavalla, Córdova, Hernández, Heymann, Garlet, Sorsa, Pärnänen, Lee, Golub, Vernal and Kantarci.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 27 December 2018
                : 03 July 2019
                Page count
                Figures: 4, Tables: 0, Equations: 0, References: 281, Pages: 24, Words: 21815
                Funding
                Funded by: National Institutes of Health 10.13039/100000002
                Categories
                Immunology
                Review

                Immunology
                osteoimmunology,oral,maxillofacial,periodontal disease,biomarkers
                Immunology
                osteoimmunology, oral, maxillofacial, periodontal disease, biomarkers

                Comments

                Comment on this article